These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19672117)

  • 1. Higher survival rates of chronic hemodialysis patients on anti-hypertensive drugs.
    Iseki K; Shoji T; Nakai S; Watanabe Y; Akiba T; Tsubakihara Y;
    Nephron Clin Pract; 2009; 113(3):c183-90. PubMed ID: 19672117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan.
    Iseki K; Nakai S; Shinzato T; Morita O; Shinoda T; Kikuchi K; Wada A; Kimata N; Akiba T
    Ther Apher Dial; 2007 Jun; 11(3):183-8. PubMed ID: 17497999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of prescribed dialysis dose and survival in a cohort of chronic hemodialysis patients.
    Iseki K; Tozawa M; Takishita S
    Clin Exp Nephrol; 2003 Sep; 7(3):231-7. PubMed ID: 14586720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between mean arterial pressure and mortality in chronic hemodialysis patients.
    Wang SM; Cheng SY; Chou CY; Liu JH; Lin HH; Tseng YH; Liu YL; Chen W; Huang CC
    Kidney Blood Press Res; 2009; 32(2):99-105. PubMed ID: 19342862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
    Fang W; Oreopoulos DG; Bargman JM
    Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of relative blood volume-controlled hemodialysis on blood pressure and volume status in hypertensive patients.
    Dasselaar JJ; Huisman RM; de Jong PE; Burgerhof JG; Franssen CF
    ASAIO J; 2007; 53(3):357-64. PubMed ID: 17515729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of initial blood pressure on the mortality of diabetics undergoing renal replacement therapy.
    Abderrahim E; Zouaghi K; Kheder A; Cherif M; Boubaker K; Mahfoudhi M; Hedri H; Ounissi M; Ben Hamida F; Ben Moussa F; Ben Abdallah T; El Younsi F; Kâaroud H; Béji S; Goucha R; Ben Maïz H
    Transplant Proc; 2004; 36(6):1820-3. PubMed ID: 15350486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.
    Velasquez MT; Lew SQ; von Albertini B; Mishkin GJ; Bosch JP
    Clin Nephrol; 1997 Dec; 48(6):341-5. PubMed ID: 9438091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis.
    Kawamura M; Fijimoto S; Hisanaga S; Yamamoto Y; Eto T
    Am J Kidney Dis; 1998 Jun; 31(6):991-6. PubMed ID: 9631844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current state of chronic dialysis treatment in Japan (as of December 31, 2000).
    Ther Apher Dial; 2003 Feb; 7(1):3-35. PubMed ID: 12921111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.